drugset / Trial / NCT00605176

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

NCT00605176

Phase 3 Completed 479 enrolled Graceway Pharmaceuticals, LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether imiquimod creams are effective in treating Actinic Keratoses when applied to the face or balding scalp. Actinic keratosis (AK) is a skin condition that shows up on skin routinely exposed to the sun, such as the face, scalp, shoulders, chest, back, arms, and hands. The active ingredient contained in the study cream for this study is the same as that of the approved product Aldara, which has been shown to be safe and effective for the treatment of AKs.

Timeline

Start
2008-01
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imiquimod Other / unclassified 2.5 % Topical
Comparator Imiquimod Other / unclassified 3.75 % Topical

Indications